Business Standard |
Dr Reddy’s, Intas to tap India’s Herceptin market
Business Standard DRL, the first company to launch a monoclonal antibody biosimilar in India, had launched Reditux (Rituximab) used in the treatment of Non-Hodgkin’s lymphoma (a kind of blood cancer) in 2007. On plans of launching Herceptin biosimilar, a DRL … |
The Nutrition Required in Chronic Kidney Disease by Healthy Kidney Publishing – SBWire (press release)
The Nutrition Required in Chronic Kidney Disease by Healthy Kidney PublishingSBWire (press release)Paramus, NJ — (SBWIRE) — 08/20/2013 — Your kidneys are filtering organs that clean your bloodstream by simply removing wastes in addition to excess es…
Evidence For The Near Death Experience? Certain Brain Waves Increase After … – Carbonated.tv
|
Evidence For The Near Death Experience? Certain Brain Waves Increase After …
Carbonated.tv The near death experience, depicted in this artwork, is a frequently described, but little understood phenomenon. The “near-death experience” is one of the weirdest known human phenomena: people who are on the brink of death but survive often have … |
Bill Frist Fast Facts – CNN
|
Bill Frist Fast Facts
CNN Timeline: 1986-1993 – Staff surgeon at the Nashville Veterans Administration Hospital and assistant professor of surgery at Vanderbilt University’s School of Medicine. 1986-1993 – Founder and director of the multi-organ transplantation program at … |
Changing organ donor districts could shorten wait for transplants – 10News
Changing organ donor districts could shorten wait for transplants10NewsJust 6,256 patients received a liver transplant last year, all but a few hundred from deceased donors. Nearly 16,000 people are awaiting a liver. About 1,500 people die waiting ever…
Celgene Corporation (NASDAQ:CELG) became Collaborater of Adimab in … – eFinance Hub
|
Celgene Corporation (NASDAQ:CELG) became Collaborater of Adimab in …
eFinance Hub Celgene Corporation (NASDAQ:CELG) became a part of the ranks of the biotech company Adimab’s collaborators, which now contain many of the largest pharma and biotech companies in the world. The Summit Corporation (LON:SUMM), NJ-based … Adimab Announces New Antibody Discovery Collaboration with Celgene …4-traders (press release) Adimab Teams Up With Celgene, Innovent, in Latest Partnership DealsXconomy Adimab Scores Two Deals and Some Milestone PaymentsGenetic Engineering News PharmiWeb.com (press release) –FierceBiotech all 8 news articles » |
The better heart failure patients know docs, the better their survival rates – FierceHealthcare
|
The better heart failure patients know docs, the better their survival rates
FierceHealthcare Heart failure patients who follow up with a familiar doctor after being discharged from the hospital have a higher survival rate and lower readmission rate than those seeing a doctor they don’t know, according to research published Monday in the … Returning To Visit Doctor After Hospital Stay Pays Off After Heart Failure …Huffington Post Physician continuity important in reducing HF outcomesTheHeart.Org |
Organ donation challenge defeated – Irish Independent
Irish Independent |
Organ donation challenge defeated
Irish Independent “Apart from putting Ireland in conflict with European legislation, such an approach would remove the statutory basis for vital aspects of a quality system for an organ donation and transplantation service, thus exposing the citizens of our country to … legislation will not increase transplantationsIrish Times Seanad motion on organ donation defeatedRTE.ie Seanad organ donation motion defeatedIrish Health Belfast Telegraph –Irish Examiner –Insideireland.ie all 32 news articles » |
Congestive heart failure affects the body's fluid volume – The Detroit News
|
Congestive heart failure affects the body’s fluid volume
The Detroit News Dear Dr. Roach: My husband was hospitalized with congestive heart failure. He returned home, grew weaker, and after three days was diagnosed with severe dehydration and passed away the following day. How can that happen so quickly? Can medication … |
The whys and hows of rituximab in thyroid eye disease – ModernMedicine
|
The whys and hows of rituximab in thyroid eye disease
ModernMedicine “Immunobiologic agents are used early in patients with thyroid eye disease,” said Simeon Lauer, MD, clinical associate professor, Albert Einstein College of Medicine, Bronx, NY. “In most cases when an immunologic agent is thought to be needed, it is not. |